Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model
暂无分享,去创建一个
A. Boos | A. Arkudas | R. Horch | J. Beier | U. Kneser | A. Dragu | O. Bleiziffer | H. Gulle | G. Deschler | J. Loew | Johanna S. Loew
[1] Stefan Milz,et al. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. , 2010, Biomaterials.
[2] Andreas Hess,et al. Axial vascularization of a large volume calcium phosphate ceramic bone substitute in the sheep AV loop model , 2010, Journal of tissue engineering and regenerative medicine.
[3] R P Pirraco,et al. Cell interactions in bone tissue engineering , 2009, Journal of cellular and molecular medicine.
[4] L. Sensébé,et al. Bone regeneration: the stem/progenitor cells point of view , 2009, Journal of cellular and molecular medicine.
[5] P. MacAry,et al. A subpopulation of mesenchymal stromal cells with high osteogenic potential , 2009, Journal of cellular and molecular medicine.
[6] Y. Verma,et al. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine , 2009, Journal of cellular and molecular medicine.
[7] J. Schrooten,et al. A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling , 2009, Journal of cellular and molecular medicine.
[8] S. Gronthos,et al. Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells , 2009, Journal of cellular physiology.
[9] Casey K Chan,et al. Cell therapy for bone regeneration--bench to bedside. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.
[10] A. Gill,et al. Mesenchymal stem cells: isolation, characterisation and in vivo fluorescent dye tracking. , 2008, Heart, lung & circulation.
[11] H. Friess,et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma , 2008, British Journal of Cancer.
[12] G. Finkenzeller,et al. In vivo engineering of a human vasculature for bone tissue engineering applications , 2008, Journal of cellular and molecular medicine.
[13] M. Mastrogiacomo,et al. Regeneration of large bone defects in sheep using bone marrow stromal cells , 2008, Journal of tissue engineering and regenerative medicine.
[14] C. Siebert,et al. BMP-2 Incorporated in a Tricalcium Phosphate Bone Substitute Enhances Bone Remodeling in Sheep , 2008, Journal of biomaterials applications.
[15] N. Selvamurugan,et al. Effects of BMP‐2 and pulsed electromagnetic field (PEMF) on rat primary osteoblastic cell proliferation and gene expression , 2007, Journal of Orthopaedic Research.
[16] Ulrich Kneser,et al. Fibrin Gel-Immobilized VEGF and bFGF Efficiently Stimulate Angiogenesis in the AV Loop Model , 2007, Molecular medicine.
[17] F. Mouquet,et al. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? , 2007, The Journal of thoracic and cardiovascular surgery.
[18] C. Bony,et al. Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model , 2007, Annals of the rheumatic diseases.
[19] Ulrich Kneser,et al. Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts. , 2007, Tissue engineering.
[20] H. Ohgushi,et al. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein‐2 (BMP‐2) and fibroblast growth factor‐2 (FGF‐2) , 2007, Journal of tissue engineering and regenerative medicine.
[21] G. Muzio,et al. Development of glass-ceramic scaffolds for bone tissue engineering: characterisation, proliferation of human osteoblasts and nodule formation. , 2007, Acta biomaterialia.
[22] N. Ishiguro,et al. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages , 2007, Acta orthopaedica.
[23] John E Mayer,et al. Endothelial progenitor and mesenchymal stem cell-derived cells persist in tissue-engineered patch in vivo: application of green and red fluorescent protein-expressing retroviral vector. , 2006, Tissue engineering.
[24] G. Blunn,et al. Do autologous mesenchymal stem cells augment bone growth and contact to massive bone tumor implants? , 2006, Tissue engineering.
[25] U Kneser,et al. Tissue engineering of bone: the reconstructive surgeon's point of view , 2006, Journal of cellular and molecular medicine.
[26] Christina Eckhardt,et al. Vascular Endothelial Growth Factor Gene‐Activated Matrix (VEGF165‐GAM) Enhances Osteogenesis and Angiogenesis in Large Segmental Bone Defects , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] J. Burkus,et al. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. , 2005, The Journal of bone and joint surgery. American volume.
[28] Xuebin B. Yang,et al. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. , 2004, Tissue engineering.
[29] B. Schmidt-Rohlfing,et al. Stimulation of bone formation with an in situ setting tricalcium phosphate/rhBMP-2 composite in rats. , 2003, Journal of biomedical materials research. Part A.
[30] A. Vaccaro. The role of the osteoconductive scaffold in synthetic bone graft. , 2002, Orthopedics.
[31] A Boyde,et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. , 2000, Journal of biomedical materials research.
[32] G. Muschler,et al. Bone graft materials. An overview of the basic science. , 2000, Clinical orthopaedics and related research.
[33] H. Oppermann,et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. , 1992, The Journal of biological chemistry.
[34] H. Oppermann,et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. , 1990, The Journal of biological chemistry.
[35] Andreas Hess,et al. De novo generation of axially vascularized tissue in a large animal model , 2009, Microsurgery.